TMDX Positive Sentiment
TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Tuesday, November 18, 2025 BiopharmaWatch Research 1 min read Key Takeaway: TransMedics Group, Inc. will participate in the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025. The management team will engage in a fireside chat at 9:30 a.m. ET. A live and archived webcast will be available on their investor website, highlighting their advancements in organ transplant therapy.
Full Press Release Details
ANDOVER, Mass.,Nov. 18, 2025/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Piper Sandler 37thAnnual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 2, 2025, at 9:30 a.m. Eastern Time.
Event: Piper Sandler 37thAnnual Healthcare ConferenceDate: Tuesday, December 2, 2025Time: 9:30 a.m. ET
A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at
https://investors.transmedics.com. The Company's standard investor presentation is also available through this link.
About TransMedics Group, Inc.TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
Investor Contact:Brian JohnstonLaine Morgan332-895-3222[email protected]